Clinical Trials Browser

Interventional × COVID-19 × BNT162 Vaccine × Clear all

NCT05016622 2024-07-31

Booster Dose Trial

Phase 2 Terminated

106 enrolled 39 charts

COVID-19, Neoplasms

NCT05075538 2024-01-17

I-SPARC

Phase 4 Terminated

COVID-19, Neoplasms

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms